Codeine phosphate 2 mg/ML / guaifenesin 40 mg/ML / phenylpropanolamine hydrochloride 2.5 mg/ML Oral Solution [Naldecon CX]
RxNorm 996544
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 996544 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: codeine phosphate 2 mg/ML / guaifenesin 40 mg/ML / phenylpropanolamine hydrochloride 2.5 mg/ML Oral Solution [Naldecon CX].
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Codeine phosphate 2 mg/ML / guaifenesin 40 mg/ML / phenylpropanolamine hydrochloride 2.5 mg/ML Oral Solution [Naldecon CX]
(Atom ID: 12404659)
TMSY
Tall Man Lettering Synonym (TMSY):
Codeine phosphate 2 mg/ML / guaiFENesin 40 mg/ML / phenylpropanolamine hydrochloride 2.5 mg/ML Oral Solution [Naldecon CX]
(Atom ID: 12406339)
SY
Synonym (SY):
Naldecon CX (codeine phosphate 10 mg / guaifenesin 200 mg / phenylpropanolamine HCl 12.5 mg) per 5 mL Oral Solution
(Atom ID: 12404660)
TMSY